Estimated reading time: 0 minutes, 26 seconds

Health technology company Medopad has a successful round of funding for its project that hopes to use big data to manage chroni diseases, reports Venture Beat. 

Medopad, a U.K.-based health technology startup that uses machine learning and big data analyses to help predict and manage chronic diseases, has raised $25 million in a series B round of funding led by Leaps by Bayer, the VC arm of German pharmaceutical giant Bayer, with participation from NWS Holdings and Healthbox, among other investors.

Read 423 times
Rate this item
(0 votes)

All the news

Visit other PMG Sites:

click me
PMG360 is committed to protecting the privacy of the personal data we collect from our subscribers/agents/customers/exhibitors and sponsors. On May 25th, the European's GDPR policy will be enforced. Nothing is changing about your current settings or how your information is processed, however, we have made a few changes. We have updated our Privacy Policy and Cookie Policy to make it easier for you to understand what information we collect, how and why we collect it.
Ok Decline